Comments

AbbVie Stock Price, Quotes and Forecasts

Q: What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

ABBVNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$210.01

-1.95-0.92%

At close: -

$210.10

0.090.04%

After Hours: Mar 21, 6:21 PM EDT

AbbVie (ABBV) Forecast

News Earnings AbbVie (ABBV) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

AbbVie Stock Price, Quotes and Forecasts | NYSE:ABBV | Benzinga

Explore AbbVie stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABBV.

Open	$211.73
Close	$210.01
Volume / Avg.	16.66M / 6.03M
Day Range	$208.74 - $212.88
52 Wk Range	153.58 - 218.66
Market Cap	$370.90B
P/E Ratio	88.69
Dividend Yield	3.09%
Exchange	NYSE
RSI	58
Short Interest	1.05%
Days to Cover	2.8

Recent News

AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits and consistent safety data.

Vandana Singh

AbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race

AbbVie partners with Gubra in a $2.2 billion deal to develop GUB014295, an amylin analog for obesity. The move marks AbbVie's entry into the competitive weight-loss market.

Vandana Singh

4 Sectors That Thrive When Inflation Runs Hot

On February 28, investors will get the January reading of the Personal Consumption Expenditure (PCE) index. Spoiler alert: it's expected to show inflation continues to run hot. While many investors may decide to flee

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$211.73
Close	$210.01
Volume / Avg.	16.66M / 6.03M
Day Range	$208.74 - $212.88
52 Wk Range	153.58 - 218.66
Market Cap	$370.90B
P/E Ratio	88.69
Dividend Yield	3.09%
Exchange	NYSE
RSI	58
Short Interest	1.05%
Days to Cover	2.8

About Abbvie Inc

Sector

Health Care

Industry

Biotechnology

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinv...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AbbVie (ABBV) stock?

You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.

View our list of the best stock brokerages

Who are AbbVie (ABBV) competitors?

Other companies in AbbVie’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for AbbVie (ABBV) stock?

AbbVie has a consensus price target of $196.50.

What is the current price for AbbVie (ABBV)?

The stock price for AbbVie (NYSE: ABBV) is $210.1 last updated March 21, 2025 at 6:21 PM EDT.

Does AbbVie (ABBV) pay a dividend?

A quarterly cash dividend of 1.64 per share of Class A Common Stock. The quarterly cash dividend was payable on February 14, 2025 to stockholders of record on January 15, 2025.

When is AbbVie (NYSE:ABBV) reporting earnings?

AbbVie’s Q1 earnings are confirmed for Friday, April 25, 2025.

Is AbbVie (ABBV) going to split?

There is no upcoming split for AbbVie.

What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.